GT
GNOM icon

Glenmede Trust’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Glenmede Trust’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$19.9K Hold
625
– – ﹤0.01% 1341
2024
Q4 		$24.3K Hold
625
– – ﹤0.01% 1355
2024
Q3 		$28.1K Hold
625
– – ﹤0.01% 1339
2024
Q2 		$26.1K Hold
625
– – ﹤0.01% 1309
2024
Q1 		$28.4K Buy
+625
New +$28.5K ﹤0.01% 1290

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Glenmede Trust's GNOM Position: Q1 2025 in Review

Glenmede Trust held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q1 2025 at 625 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1341.

Glenmede Trust first reported a position in GNOM in Q1 2024 and has held it in 5 quarters since. The position peaked at $28.4K in Q1 2024. 60 funds tracked by Wall St. Rank hold GNOM as of Q1 2025.

  • Glenmede Trust held 625 shares of Global X Genomics & Biotechnology ETF worth $19.9K as of Q1 2025.
  • Glenmede Trust left its Global X Genomics & Biotechnology ETF share count unchanged in Q1 2025.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2025, its #1341 holding.
  • Glenmede Trust first reported a position in Global X Genomics & Biotechnology ETF in Q1 2024 and has held it in 5 quarters since.
  • Glenmede Trust's Global X Genomics & Biotechnology ETF position peaked at $28.4K in Q1 2024.
  • 60 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2025.

Based on Glenmede Trust's 13F filing for Q1 2025, filed 15 May 2025.